Annual Cash & Cash Equivalents
$151.90 K
-$943.00 K-86.13%
December 31, 2023
Summary
- As of February 7, 2025, MEDS annual cash & cash equivalents is $151.90 thousand, with the most recent change of -$943.00 thousand (-86.13%) on December 31, 2023.
- During the last 3 years, MEDS annual cash & cash equivalents has fallen by -$5.77 million (-97.43%).
Performance
MEDS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$579.10 K
-$7.14 M-92.50%
September 30, 2024
Summary
- As of February 7, 2025, MEDS quarterly cash and cash equivalents is $579.10 thousand, with the most recent change of -$7.14 million (-92.50%) on September 30, 2024.
- Over the past year, MEDS quarterly cash and cash equivalents has dropped by -$2.92 million (-83.45%).
Performance
MEDS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MEDS Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -86.1% | -83.5% |
3 y3 years | -97.4% | -83.8% |
5 y5 years | -82.5% | -82.8% |
MEDS Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -95.1% | at low | -92.5% | -94.1% |
5 y | 5-year | -97.4% | at low | -92.5% | -94.1% |
alltime | all time | -97.4% | -98.8% | -92.5% | -99.9% |
TRxADE HEALTH Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $579.10 K(-92.5%) |
Jun 2024 | - | $7.72 M(+120.6%) |
Mar 2024 | - | $3.50 M(+2203.4%) |
Dec 2023 | $151.90 K(-86.1%) | $151.90 K(+346.8%) |
Sep 2023 | - | $34.00 K(-95.4%) |
Jun 2023 | - | $745.60 K(-37.6%) |
Mar 2023 | - | $1.19 M(+9.1%) |
Dec 2022 | $1.09 M(-64.9%) | $1.09 M(+240.3%) |
Sep 2022 | - | $321.70 K(-66.6%) |
Jun 2022 | - | $962.20 K(-48.6%) |
Mar 2022 | - | $1.87 M(-40.1%) |
Dec 2021 | $3.12 M(-47.2%) | $3.12 M(-12.6%) |
Sep 2021 | - | $3.57 M(-21.0%) |
Jun 2021 | - | $4.52 M(-13.2%) |
Mar 2021 | - | $5.21 M(-12.0%) |
Dec 2020 | $5.92 M(+106.1%) | $5.92 M(-11.0%) |
Sep 2020 | - | $6.65 M(+60.1%) |
Jun 2020 | - | $4.15 M(-46.1%) |
Mar 2020 | - | $7.70 M(+168.2%) |
Dec 2019 | $2.87 M(+230.2%) | $2.87 M(-14.5%) |
Sep 2019 | - | $3.36 M(+522.1%) |
Jun 2019 | - | $540.00 K(+1.1%) |
Mar 2019 | - | $533.90 K(-38.6%) |
Dec 2018 | $869.60 K(+372.9%) | $869.60 K(+46.7%) |
Sep 2018 | - | $592.80 K(+185.1%) |
Jun 2018 | - | $207.90 K(+9.5%) |
Mar 2018 | - | $189.80 K(+3.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $183.90 K(+1151.0%) | $183.90 K(+6.1%) |
Sep 2017 | - | $173.30 K(+67.9%) |
Jun 2017 | - | $103.20 K(-39.3%) |
Mar 2017 | - | $170.00 K(+1056.5%) |
Dec 2016 | $14.70 K(-81.3%) | $14.70 K(-84.5%) |
Sep 2016 | - | $94.60 K(-70.4%) |
Jun 2016 | - | $319.60 K(-37.1%) |
Mar 2016 | - | $508.30 K(+545.9%) |
Dec 2015 | $78.70 K(-88.8%) | $78.70 K(-75.8%) |
Sep 2015 | - | $324.60 K(-21.6%) |
Jun 2015 | - | $414.20 K(+23.5%) |
Mar 2015 | - | $335.30 K(-52.5%) |
Dec 2014 | $705.60 K(+737.0%) | $705.60 K(+160.6%) |
Sep 2014 | - | $270.80 K(+284.1%) |
Jun 2014 | - | $70.50 K(-16.4%) |
Dec 2013 | $84.30 K(-87.7%) | $84.30 K(>+9900.0%) |
Sep 2009 | - | $600.00(0.0%) |
Jun 2009 | - | $600.00(-14.3%) |
Mar 2009 | - | $700.00(-99.9%) |
Dec 2008 | $687.00 K(>+9900.0%) | $687.00 K(>+9900.0%) |
Sep 2008 | - | $300.00(-62.5%) |
Jun 2008 | - | $800.00(+14.3%) |
Mar 2008 | - | $700.00(-61.1%) |
Dec 2007 | $1800.00(-86.4%) | $1800.00(-25.0%) |
Sep 2007 | - | $2400.00(-73.6%) |
Jun 2007 | - | $9100.00(-31.1%) |
Dec 2006 | $13.20 K | $13.20 K |
FAQ
- What is TRxADE HEALTH annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for TRxADE HEALTH?
- What is TRxADE HEALTH annual cash & cash equivalents year-on-year change?
- What is TRxADE HEALTH quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for TRxADE HEALTH?
- What is TRxADE HEALTH quarterly cash and cash equivalents year-on-year change?
What is TRxADE HEALTH annual cash & cash equivalents?
The current annual cash & cash equivalents of MEDS is $151.90 K
What is the all time high annual cash & cash equivalents for TRxADE HEALTH?
TRxADE HEALTH all-time high annual cash & cash equivalents is $5.92 M
What is TRxADE HEALTH annual cash & cash equivalents year-on-year change?
Over the past year, MEDS annual cash & cash equivalents has changed by -$943.00 K (-86.13%)
What is TRxADE HEALTH quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MEDS is $579.10 K
What is the all time high quarterly cash and cash equivalents for TRxADE HEALTH?
TRxADE HEALTH all-time high quarterly cash and cash equivalents is $7.72 M
What is TRxADE HEALTH quarterly cash and cash equivalents year-on-year change?
Over the past year, MEDS quarterly cash and cash equivalents has changed by -$2.92 M (-83.45%)